Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Results Details (159)

SortShow
Name Institution Why
Irene Ghobrial, M.D.Dana-Farber Cancer Institute Why?
Giada Bianchi, M.D.Dana-Farber Cancer Institute Why?
Kenneth Carl Anderson, M.D.Dana-Farber Cancer Institute Why?
Paul Gerard Guy Richardson, M.B.,B.S.Dana-Farber Cancer Institute Why?
Miriam A. Bredella, M.D.Massachusetts General Hospital Why?
Nikhil C Munshi, M.D., M.B.,B.S.Dana-Farber Cancer Institute Why?
Steven P. Treon, M.D., Ph.D.Dana-Farber Cancer Institute Why?
Jorge Castillo, M.D.Dana-Farber Cancer Institute Why?
Mark Bustoros, M.D.Dana-Farber Cancer Institute Why?
David Peter Steensma, M.D.Dana-Farber Cancer Institute Why?
Robert Paul Hasserjian, M.D.Massachusetts General Hospital Why?
Stephen P. Juraschek, Ph.D., M.D.Beth Israel Deaconess Medical Center Why?
Valentina Nardi, M.D.Massachusetts General Hospital Why?
Franziska L. Michor, Ph.D(Habil)Harvard T.H. Chan School of Public Health Why?
F. Joseph Simeone, M.D.Massachusetts General Hospital Why?
Per Page    Page  of 11last Nextnext
Prev
Search Criteria
  • Monoclonal Gammopathy of Undetermined Significance
Click "Why?" to see why a person matched the search.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.